Charles River Laboratories is boosting its capacity to understand how the immune cell compartment works within the tumor microenvironment under a new deal with Cypre Inc. The nonclinical CRO will work ...

Charles River Laboratories International, Inc. CRL entered into an agreement with German biotech company, CELLphenomics. Through the partnership, Charles River clients will have access to ...

Collaboration will provide access to Falcon-X™ 3D Tumor Model Platform The Falcon-X™ 3D In Vitro Tumor Assay Platform is a high content analysis screening option for cancer immunotherapy and targeted ...

Engineers who need to integrate river-flow analysis data with 3D civil design models recently got a boost with the release of a new extension that ties them together. Until the end of the year, ...